Tested parameters | Category | Serum ferritin >200 ng/ml | Bivariate analysis | Multivariate analysis | |||
---|---|---|---|---|---|---|---|
Yes (n=54) | No (n=50) | COR(95% CI) | P | AOR(95% CI) | P | ||
Age (yrs)a | 18-33 | 10 | 5 | 1 | Â | Â | Â |
34-49 | 23 | 21 | 0.55(0.16-1.87) | 0.336 | 0.43(0.06-2.94) | 0.389 | |
50-65 | 21 | 24 | 0.44(0.13-1.49) | 0.185 | 0.19(0.02-1.50) | 0.115 | |
Sexa | Male | 33 | 15 | 1 | Â | Â | Â |
Female | 21 | 35 | 0.27(0.12-0.62) | 0.002 | 0.16(0.05-0.57) | 0.004 | |
Educational levelsb | No formal | 5 | 6 | 1 | Â | Â | Â |
Primary | 15 | 14 | 1.29(0.32-5.18) | 0.724 | Â | Â | |
Secondary | 22 | 16 | 1.65(0.43-6.37) | 0.467 | Â | Â | |
Higher | 12 | 14 | 1.03(0.25-4.24) | 0.969 | Â | Â | |
BMI(kg/m2)a | <18.5 | 3 | 3 | 1 | Â | Â | Â |
18.5-24.9 | 13 | 24 | 0.54(0.09-3.08) | 0.489 | 0.12(0.01-1.46) | 0.097 | |
25-29.9 | 28 | 21 | 1.33(0.24-7.28) | 0.740 | 0.44(0.04-4.42) | 0.485 | |
≥30 | 10 | 2 | 5.0(0.55-45.39) | 0.153 | 2.27(0.09-57.2) | 0.618 | |
SBP(mmHg)a | <120 | 8 | 13 | 1 | Â | Â | Â |
120-139 | 24 | 24 | 1.63(0.57-4.63) | 0.363 | 1.48(0.33-6.73) | 0.610 | |
≥140 | 22 | 13 | 2.75(0.90-8.40) | 0.076 | 1.56(0.25-9.81) | 0.637 | |
DBP(mmHg)a | <80 | 15 | 19 | 1 | Â | Â | Â |
80-89 | 21 | 22 | 1.21(0.49-2.98) | 0.680 | 0.50(0.12-2.23) | 0.365 | |
≥90 | 18 | 9 | 2.53(0.89-7.23) | 0.082 | 0.48(0.08-2.89) | 0.425 | |
Duration on DM (yrs)a | <5 | 12 | 8 | 1 | Â | Â | Â |
5-10 | 17 | 23 | 0.49(0.17-1.47) | 0.204 | 0.80(0.16-4.06) | 0.788 | |
>10 | 25 | 19 | 0.88(0.30-2.57) | 0.811 | 0.35(0.05-2.30) | 0.276 | |
Mode of therapy a | OHA | 41 | 27 | 1 | Â | Â | Â |
Insulin | 13 | 23 | 0.37(0.16-0.86) | 0.020 | 0.26(0.07-0.95) | 0.042 | |
HbA1c (%)a | M±SD | 8.8 ±1.9 | 7.1± 1.0 | 2.12(1.50-3.01) | <0.001 | 3.67(1.50-8.98) | 0.004 |
FBs (mg/dl)a | M±SD | 176.4±59.2 | 136.1±42.4 | 1.02(1.01-1.03) | <0.001 | 0.99(0.97-1.01) | 0.233 |
Serum iron (ug/dl)a | M±SD | 142.8±33.9 | 114.2±32.6 | 1.03(1.01-1.04) | <0.001 | 1.02(1.01-1.04) | 0.017 |